GL1X · GenesisL1 explorer

MolNFT v1 · #14072 · protein

Crystal structure of E. COLI enoyl reductase-NAD+ with a bound acrylamide inhibitor

1LXC · Enoyl-[acyl-carrier-protein] reductase [NADH]: “Crystal structure of E. COLI enoyl reductase-NAD+ with a bound acrylamide inhibitor”. X-ray diffraction, 2 ligands (NAD, AYM), 5 pockets (best druggability 0.71). MolNFT v1 #14072 on…

PDB
1LXC
Type
protein
Length
502 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Enoyl-[acyl-carrier-protein] reductase [NADH]
EC
1.3.1.9
UniProt
P29132
Ligands
NAD, AYM
Pockets
5 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BEnoyl-[acyl-carrier-protein] reductase [NADH] (EC 1.3.1.9)protein25149% helix, 15% strandP29132

Ligands and binding sites

  • NAD · Nicotinamide-adenine-dinucleotide · ligand · 2 copies · chains A, B
  • AYM · 3-(6-aminopyridin-3-yl)-N-methyl-N-[(1-methyl-1H-indol-2-yl)methyl]acrylamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15820.710.7944NAD, AYM
25480.710.7941NAD, AYM
3860.390.7713empty
4780.330.7417empty
5630.300.7413empty

Interfaces

1 interface between chains.

  • A–B · 1702 Ų buried · 44 hydrogen bonds · protein-protein

Compared structures

  • 1LXC · Crystal Structure of E. Coli Enoyl Reductase-NAD+ with a Bound Acrylamide Inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.